5 authorised products containing Abatacept, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Orencia 125 mg solution for injection in pre-filled pen EU/1/07/389/004-009 |
Abatacept | Bristol-Myers Squibb Pharma EEIG | — |
| Orencia 125 mg solution for injection in pre-filled pen EU/1/07/389/011-012 |
Abatacept | Bristol-Myers Squibb Pharma EEIG | — |
| Orencia 250 mg powder for concentrate for solution for infusion EU/1/07/389/1-3 |
Abatacept | Bristol-Myers Squibb Pharma EEIG | — |
| Orencia 50 mg solution for injection in pre-filled syringe EU/1/07/389/013 |
Abatacept | Bristol-Myers Squibb Pharma EEIG | — |
| Orencia 87.5 mg solution for injection in pre-filled syringe EU/1/07/389/014 |
Abatacept | Bristol-Myers Squibb Pharma EEIG | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.